Comparison between indexes of insulin resistance for risk prediction of cardiovascular diseases or development of diabetes

Diabetes Research and Clinical Practice

Volumn 110, Issue 2, 2015, Pages 183-192

  Zethelius, Björn ^a,b   Cederholm, Jan ^c  

^a UPPSALA UNIVERSITY   (Sweden)

^b MEDICAL PRODUCTS AGENCY   (Sweden)

^c UPPSALA UNIVERSITY   (Sweden)

Author keywords

Cardiovascular diseases; Diabetes mellitus; Insulin clamp test; Insulin resistance; Myocardial infarction

Indexed keywords

GLUCOSE; INSULIN;

AGED; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DIABETOGENESIS; FOLLOW UP; GLUCOSE TRANSPORT; HUMAN; HYPERINSULINEMIC-EUGLYCEMIC CLAMP TECHNIQUE; INSULIN RESISTANCE; ISCHEMIC HEART DISEASE; MALE; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; RISK ASSESSMENT; BLOOD; CARDIOVASCULAR DISEASES; COMPARATIVE STUDY; DIABETES MELLITUS; INCIDENCE; ODDS RATIO; RISK FACTOR; SWEDEN;

AGED; CARDIOVASCULAR DISEASES; DIABETES MELLITUS; HUMANS; INCIDENCE; INSULIN; INSULIN RESISTANCE; MALE; ODDS RATIO; RISK FACTORS; SWEDEN;

EID: 84962877612     PISSN: 01688227     EISSN: 18728227     Source Type: Journal    
DOI: 10.1016/j.diabres.2015.09.003     Document Type: Article

References (46)

1. Martin B.C., Warram J.H., Krolewski A.S., Bergman R.N., Soeldner J.S., Kahn C.R. Role of glucose and insulin resistance in development of type 2 diabetes mellitus: results of a 25-year follow-up study. Lancet 2003, 340:925-929.
2. Lillioja S., Mott D.M., Spraul M., Ferraro R., Foley J.E., Bennett P.H., et al. Insulin resistance and insulin secretary dysfunction as precursors of non-insulin-dependent diabetes mellitus: prospective studies of Pima Indians. N Engl J Med 1993, 329:1988-1992.
3. DeFronzo R.A. Insulin resistance, lipotoxicity, type 2 diabetes and atherosclerosis: the missing links. The Claude Bernard Lecture 2009. Diabetologia 2010, 53:1270-1287.
4. Razani B., Chakravarthy M.V., Semenkovich C.F. Insulin resistance and atherosclerosis. Endocrinol Metab Clin North Am 2008, 37:603-621.
5. Yip J., Facchini F., Reaven G.M. Resistance to insulin-mediated glucose disposal as a predictor of cardiovascular disease. J Clin Endocrinol Metab 1998, 88:2773-2776.
6. DeFronzo R.A., Tobin J.D., Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 1979, 237:E214-E223.
7. Consensus Development Conference on Insulin Resistance. Diabetes Care 1998, 21:310-314. American Diabetes Association.
8. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., Turner R.C. Homeostasis model assessment: insulin resistance and cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985, 28:412-419.
9. Levy J.C., Matthews D.R., Hermans M.P. Correct homeostasis model assessment (HOMA) evaluation uses the computer program. Diabetes Care 1998, 21:2191-2192.
10. Rutter M.K., Wilson P.W.F., Sullivan L.M., Fox C.S., D'Agostino R.B., Meigs J.B. Use of alternative thresholds defining insulin resistance to predict incident type 2 diabetes mellitus and cardiovascular disease. Circulation 2008, 117:1003-1009.
11. Matsuda M., DeFronzo R.A. Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 1999, 22:1462-1470.
12. DeFronzo R.A., Matsuda M. Reduced time points to calculate the composite index. Diabetes Care 2010, 33:e93.
13. Cederholm J., Wibell L. Insulin release and peripheral sensitivity at the oral glucose tolerance test. Diabetes Res Clin Pract 1999, 10:167-175.
14. Gutt M., Davis C.L., Spitzer S.B., Llabre M.M., Skyler J.S., Marks J.B., et al. Validation of the insulin sensitivity index (ISI0, 120): comparison with other measures. Diabetes Res Clin Pract 2000, 47:177-184.
15. Hanley A.J.G., Williams K., Gonzalez C., D'Agostino R.B., Stern M.P., Haffner S.M., et al. Prediction of type 2 diabetes using simple measures of insulin resistance: combined results from the San Antonio heart study, the Mexico city diabetes study, and the insulin resistance atherosclerosis study. Diabetes 2003, 52:463-469.
16. Belfiore F., Iannello S., Volpicelli G. Insulin sensitivity indices calculated from basal and OGTT-induced insulin, glucose and FFA levels. Mol Gen Metab 1998, 63:134-141.
17. Rutter M.K., Meigs J.B., Sullivan L.M., D'Agostino R.B., Wilson P.W. Insulin resistance, the metabolic syndrome, and incident cardiovascular events in the framingham offspring Study. Diabetes 2005, 54:3252-3257.
18. Hedstrand H. A study of middle-aged men with particular reference to risk factors for cardiovascular disease. Uppsala J Med Sci 1975, 80(Suppl. 19):1-61.
19. Byberg L., McKeigue P.M., Zethelius B., Lithell H.O. Birth weight and the insulin resistance syndrome: association of low birth weight with truncal obesity and raised plasminogen activator inhibitor-1 but not with abdominal obesity or plasmalipid disturbances. Diabetologia 2000, 43:54-60.
20. World Health Organization Definition, diagnosis and classification of diabetes mellitus and its complications: report of a WHO consultation 1999, World Health Org, Geneva, (WHO/NCD/NCS/99.2).
21. Zethelius B., Hales C.N., Lithell H.O., Berne C. Insulin resistance, impaired early insulin response, and insulin propeptides as predictors of the development of type 2 diabetes: a population-based, 7-year follow-up study in 70-year-old men. Diabetes Care 2004, 27:1433-1438.
22. Zethelius B., Lithell H., Hales C.N., Berne C. Insulin sensitivity, proinsulin and insulin as predictors of coronary heart disease. A population-based 10-year, follow-up study in 70-year-old men using the euglycaemic insulin clamp. Diabetologia 2005, 48:862-867.
23. Charlson M.E., Pompei P., Ales K.L., MacKenzie C.R. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chron Dis 1987, 40:373-383.
24. Alberti K.G., Eckel R.H., Grundy S.M., Zimmet P.Z., James W.P., Smith S.C., et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009, 120:1640-1645.
25. Merlo J., Lindblad U., Hedblad B., Rastam J., Isacsson S.O., Rastam L., et al. Comparison of different procedures to identify probable cases of myocardial infarction and stroke in two Swedish prospective cohort studies using local and national routine registers. Eur J Epidemiol 2000, 16:235-243.
26. Tunstall-Pedoe H., Kuulasmaa K., Amouyel P., Arveiler D., Rajakangas A.M., Pajak A. Myocardial infarction and coronary deaths in the World Health Organization MONICA Project. Registration procedures, event rates, and case-fatality rates in 38 populations from 21 countries in four continents. Circulation 1994, 90:583-612.
27. Bland M., Altman D.G. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986, 327:307-310.
28. Laakso M. How good a marker is insulin level for insulin resistance. Am J Epidemiol 1993, 137:959-965.
29. Sluiter W.J., Erkelens D.W., Terpstra P., Reitsma W.D., Doorenbos H. Glucose tolerance and insulin release, a mathematical approach. II. Approximation of the peripheral insulin resistance after oral glucose loading. Diabetes 1976, 25:245-249.
30. McAuley K.A., Williams S.M., Mann J.I., et al. Diagnosing insulin resistance in the general population. Diabetes Care 2001, 24:460-464.
31. Duncan M.H., Singh B.M., Wise P.H., Carter G., Alaghband-Zadeh J. A simple measure of insulin resistance. Lancet 1995, 346:120-121.
32. Raynaud E., Perez-Martin A., Brun J.F., Benhaddad A.A., Mercier J. Revised concept for the estimation of insulin sensitivity from a single sample. Diabetes Care 1999, 22:1003-1004.
33. Katz A., Nambi S.S., Mather K., Baron A.D., Sullivan G., Quon M.J., et al. Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab 2000, 85:2402-2410.
34. Hanson R.L., Pratley R.E., Bogardus C., Narayan K.M., Bennett P.H., Knowler W.C., et al. Evaluation of simple indices of insulin sensitivity and insulin secretion for use in epidemiologic studies. Am J Epidemiol 2000, 151:190-198.
35. Stumvoll M., Mitrakou A., Pimenta W., Jenssen T., Yki-Jarvinen H., Gerich J., et al. Use of the oral glucose tolerance test to assess insulin release and insulin sensitivity. Diabetes Care 2000, 23:295-301.
36. Avignon A., Boegner C., Mariano-Goulart D., Colette C., Monnier L. Assessment of insulin sensitivity from plasma insulin and glucose in the fasting or post oral glucose-load state. Int J Obes Relat Metab Disord 1999, 23:512-517.
37. Hedblad B., Nilsson P., Engström G., Berglund G., Janzon L. Insulin resistance in non-diabetic subjects is associated with increased incidence of myocardial infarction and death. Diabet Med 2002, 19:470-475.
38. Hanley A., Williams K., Stern M.P., Hafner S.M. Homeostasis model assessment of insulin resistance in relation to the incidence of cardiovascular disease. Diabetes Care 2002, 25:1177-1184.
39. Jeppsen J., Hansen T.W., Rasmussen S., Ibsen H., Torp-Pedersen C., Madsbad S. Insulin resistance, the metabolic syndrome, and risk for incident cardiovascular disease. J Am Coll Cardiol 2007, 49:2112-2119.
40. Gotoh S., Doi Y., Hata J., Ninomiya T., Mukai N., Kiyohara Y., et al. Insulin resistance and the development of cardiovascular disease in a Japanese community: the Hisayama study. J Atheroscl Thromb 2012, 19:977-985.
41. Rundek T., Gardener H., Xu Q., Goldberg R.B., Wright C.B., Sacco R.L., et al. Insulin resistance and risk of ischemic stroke among nondiabetic individuals from the Northern Manhattan study. Arch Neurol 2010, 67:1195-1200.
42. Nolan J.J., Faerch K. Estimating insulin sensitivity and beta cell function: perspectives from the modern pandemics of obesity and type 2 diabetes. Diabetologia 2012, 55:2863-2867.
43. Olefsky J.M. Insulin antagonists and resistance. Diabetes Mellitus: Theory and Practice. 1987, 151-178. Medical Examination Publishing Company, New York. 3rd ed. M. Ellenberg, H. Rifkin (Eds.).
44. Steinberg H.O., Chaker H., Leaming R., Johnson A., Brechtel G., Baron A.D. Obesity/Insulin resistance is associated with endothelial dysfunction. Implications for the syndrome of insulin resistance. J Clin Invest 1996, 97:2601-2610.
45. Festa A., D'Agostino R., Howard G., Mykkänen L., Tracy R.P., Haffner S.M. Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS). Circulation 2000, 102:42-47.
46. Meigs J., D'Agostino R.B., Wilson P.W. Hyperinsulinemia, hyperglycemia and impaired homeostasis. JAMA 2000, 283:221-228.